Stay updated on ARO-C3 in Renal Disease Clinical Trial

Sign up to get notified when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARO-C3 in Renal Disease Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the number of open-label doses of ARO-C3 that adult patients with C3 Glomerulopathy and IgA Nephropathy will receive in Part 2 of the study.
    Difference
    0.1%
    Check dated 2024-06-06T14:29:08.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying requirements such as informed consent, non-pregnancy for female participants, and general health conditions. Previously, no information was provided for participation criteria.
    Difference
    25%
    Check dated 2024-05-22T21:01:22.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:56:22.000Z thumbnail image

Stay in the know with updates to ARO-C3 in Renal Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.